A5015372140- Liver Disease and Transplantation
- Organ Transplantation Techniques and Outcomes
- Renal Transplantation Outcomes and Treatments
- Congenital Anomalies and Fetal Surgery
- Minimally Invasive Surgical Techniques
- Hematopoietic Stem Cell Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Drug-Induced Hepatotoxicity and Protection
- Abdominal Trauma and Injuries
- Gallbladder and Bile Duct Disorders
- Abdominal Surgery and Complications
Kaohsiung Medical University
2024
Kaohsiung Medical University Chung-Ho Memorial Hospital
2023-2024
Changhua Christian Hospital
2021-2022
Advancements in surgical techniques and the optimization of immunosuppression have boosted organ transplant survival rates; however, liver recipients still risk complications such as hepatic vein occlusive disease (HVOD), also called sinusoidal obstruction syndrome. Rare but potentially fatal HVOD damages endothelial cells due to factors like chemotherapy, stem cell transplantation, certain medications azathioprine tacrolimus. Typically, presents with distinct clinical symptoms, including...
Abstract Aims The use of extended criteria donors is a routine practice that sometimes involves extracorporeal membrane oxygenation (ECMO) in donations after cardiac death or brain death. Methods We performed retrospective study single center from January 2006 to December 2019. included 90 deceased donor liver transplants. patients were divided into three groups: the donation (DBD) group ( n = 58, 64.4%), DBD with ECMO 11, 12.2%) and (DCD) 21, 23.3%). Results There no significant differences...
No abstract available.
Fang-Sheng, Cheng; Shih-Chang, Chuang; Shen-Nien, Wang; Yao-Li, Chen; Hsin-Rou, Liang Author Information
The Milan criteria are the universal standard of liver transplantation for hepatocellular carcinoma (HCC). Numerous expanded have shown outcomes as good criteria. In Taiwan, living donor transplant (LDLT) accounts majority transplantations due to organ shortages.We retrospectively enrolled 155 patients who underwent LDLT HCC from July 2005 June 2017 and were followed up at least 2 years. Patients beyond (n = 78) grouped recurrent or nonrecurrent, we established new based on these...